Finance

Diagnostics company reports 16% increase in third quarter net sales

Published in Biotech Business Week, August 9th, 2004

Meridian Bioscience, Inc., (VIVO) reported that net sales for the third fiscal quarter ended June 30, 2004, were $18,256,000 as compared to $15,693,000 for the same period of the prior fiscal year, an increase of 16%.

Net earnings for the third quarter of fiscal 2004 were $2,157,000 or $0.14 per diluted share, up 18% and 17%, respectively, over the third quarter of fiscal 2003. Diluted common shares outstanding for the third quarter of fiscal 2004 and 2003 were 15,260,000 and 15,012,000, respectively.

Operating expenses for the quarter and the 9 months to date reflect increased research and development activities, higher sales commissions related to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry